Calcium antagonists in the treatment of hypertension.
Ram
C V
CV
D001693:Biological Transport, Active; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000378:metabolism / Q000627:therapeutic use*; D002216:Captopril / Q000008:administration & dosage; D004110:Diltiazem / Q000627:therapeutic use; D004232:Diuretics / Q000008:administration & dosage; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D004594:Electrophysiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D006978:Hypertension, Renovascular / Q000188:drug therapy; D007473:Ion Channels / Q000378:metabolism; D007700:Kinetics; D008750:Methyldopa / Q000008:administration & dosage; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D009543:Nifedipine / Q000008:administration & dosage / Q000627:therapeutic use; D011433:Propranolol / Q000008:administration & dosage; D012964:Sodium / Q000378:metabolism; D014655:Vascular Resistance / Q000187:drug effects; D014700:Verapamil / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D004232:Diuretics; D007473:Ion Channels; D008750:Methyldopa; D002216:Captopril; D012964:Sodium; D011433:Propranolol; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine; D002118:Calcium